Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical Technology describe mu-opioid agonists March 5, 2021
Eli Lilly presents promising data from SURPASS-2 study of tirzepatide in type 2 diabetes March 5, 2021
Bi-functionalized nanoparticles described by Vall d'Hebron Institut de Recerca and collaborators March 5, 2021
Dosing begins in phase I study of DNX-2440 in patients with resectable liver metastasis March 5, 2021
Positive phase I data support advancing FOR-6219 to phase II development in endometriosis March 5, 2021
RSS